KZR•benzinga•
Wells Fargo Maintains Equal-Weight on Kezar Life Sciences, Lowers Price Target to $11
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 14, 2024 by benzinga